King Luther Capital Management Corp Anebulo Pharmaceuticals, Inc. Put Options Transaction History
King Luther Capital Management Corp
- $22.8 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
15Shares Held
7.39MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$7.78 Million11.7% of portfolio
-
Lvw Advisors, LLC633KShares$917,1480.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$741,0550.06% of portfolio
-
Morgan Stanley New York, NY399KShares$578,8670.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$228,8990.05% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $37.2M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...